Disposition of 6600 shares by Steiner Mitchell Shuster of Veru at 2.103 subject to Rule 16b-3
VERU Stock | USD 0.68 0.05 7.94% |
Slightly above 57% of all Veru's private investors are looking to take a long position. The analysis of overall sentiment of trading Veru Inc stock suggests that some investors are interested at this time. Veru's investing sentiment can be driven by a variety of factors including economic data, Veru's earnings reports, geopolitical events, and overall market trends.
Veru |
Filed transaction by Veru Inc Director, 10 Percent Owner, Officer President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Veru's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Veru's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Veru Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Veru can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Veru Fundamental Analysis
We analyze Veru's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Veru using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Veru based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Veru is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Veru Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Veru stock to make a market-neutral strategy. Peer analysis of Veru could also be used in its relative valuation, which is a method of valuing Veru by comparing valuation metrics with similar companies.
Peers
Veru Related Equities
TSVT | 2Seventy Bio | 14.24 | ||||
LXRX | Lexicon Pharmaceuticals | 11.69 | ||||
MCRB | Seres Therapeutics | 5.48 | ||||
NVAX | Novavax | 5.35 | ||||
IOVA | Iovance Biotherapeutics | 3.76 | ||||
PBYI | Puma Biotechnology | 3.45 | ||||
SRPT | Sarepta Therapeutics | 3.38 | ||||
PLX | Protalix Biotherapeutics | 1.81 | ||||
AVXL | Anavex Life | 1.00 | ||||
AXSM | Axsome Therapeutics | 0.50 | ||||
ANVS | Annovis Bio | 2.06 |
Additional Tools for Veru Stock Analysis
When running Veru's price analysis, check to measure Veru's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veru is operating at the current time. Most of Veru's value examination focuses on studying past and present price action to predict the probability of Veru's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veru's price. Additionally, you may evaluate how the addition of Veru to your portfolios can decrease your overall portfolio volatility.